Medicare Enrolled
Dr. Jayadev Mettu, M.B.B.S
Hematology & Oncology · Fairfield, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mettu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mettu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mettu
Dr. Jayadev Mettu is a hematology & oncology specialist in Fairfield, OH, with 11 years of NPI registration. Based on federal Medicare data, Dr. Mettu performed 17,544 Medicare services across 2,122 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mettu received a total of $2,846 from 37 pharmaceutical and/or device companies across 115 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mettu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 17% volume in OH
$2,846 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,544
Medicare services
Top 17% in OH for hematology & oncology
2,122
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,595 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
7,650 | $0 | $6 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,420 | $6 | $55 |
| Iron infusion (Monoferric) | 1,800 | $17 | $74 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,078 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
790 | $8 | $35 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
574 | $10 | $62 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
350 | $64 | $205 |
| Anti-nausea injection (Aloxi/palonosetron) | 310 | $1 | $122 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
286 | $85 | $305 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
238 | $9 | $54 |
| Injection, granisetron hydrochloride, 100 mcg | 190 | $0 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
163 | $10 | $93 |
| Iron level test | 162 | $6 | $26 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
161 | $13 | $58 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
161 | $9 | $34 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
157 | $15 | $74 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
146 | $6 | $30 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
141 | $93 | $681 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
100 | $20 | $152 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
80 | $45 | $304 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
74 | $1 | $19 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
62 | $11 | $105 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
51 | $120 | $410 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
50 | $14 | $71 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
36 | $19 | $96 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
33 | $21 | $156 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
32 | $17 | $111 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
32 | $100 | $400 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
31 | $1 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
30 | $47 | $334 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
29 | $2 | $19 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $107 | $475 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
28 | $57 | $210 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
22 | $23 | $249 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 21 | $17 | $124 |
| New patient office visit, complex (60-74 min) | 17 | $159 | $590 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $134 | $585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
56.2% high complexity
24.9% medium
19.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,846
Total received (2018-2024)
Avg $407/year across 7 years
Top 48% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
115
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,538 (89.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$309 (10.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$788
2023
$658
2022
$262
2021
$293
2020
$125
2019
$480
2018
$240
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$191
Intera Oncology, Inc
$128
AstraZeneca Pharmaceuticals LP
$52
Stemline Therapeutics Inc.
$44
Incyte Corporation
$40
GENZYME CORPORATION
$40
Eisai Inc.
$38
Astellas Pharma US Inc
$33
PFIZER INC.
$31
Daiichi Sankyo Inc.
$29
BeiGene USA, Inc.
$27
Mirati Therapeutics, Inc.
$23
Genentech USA, Inc.
$21
Gilead Sciences, Inc.
$19
Lilly USA, LLC
$19
SOBI, INC
$18
GlaxoSmithKline, LLC.
$18
Tempus AI, Inc
$16
Top 3 companies account for 47.2% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$313
Amgen Inc.
$282
AstraZeneca Pharmaceuticals LP
$253
ABBVIE INC.
$191
Incyte Corporation
$167
Pharmacyclics LLC, An AbbVie Company
$150
Intera Oncology, Inc
$128
Takeda Pharmaceuticals U.S.A., Inc.
$125
Alexion Pharmaceuticals, Inc.
$121
Genentech USA, Inc.
$112
GENZYME CORPORATION
$87
Astellas Pharma US Inc
$67
Pharmacyclics LLC, an AbbVie Company
$65
Stemline Therapeutics Inc.
$64
Lilly USA, LLC
$63
Daiichi Sankyo Inc.
$58
Eisai Inc.
$56
EISAI INC.
$56
Celgene Corporation
$46
Mirati Therapeutics, Inc.
$45
PFIZER INC.
$42
Novartis Pharmaceuticals Corporation
$41
Merck Sharp & Dohme Corporation
$37
Merck Sharp & Dohme LLC
$36
Seagen Inc.
$32
BeiGene USA, Inc.
$27
Jazz Pharmaceuticals Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Gilead Sciences, Inc.
$19
SOBI, INC
$18
GlaxoSmithKline, LLC.
$18
Regeneron Healthcare Solutions, Inc.
$16
Janssen Pharmaceuticals, Inc
$16
Tempus AI, Inc
$16
Puma Biotechnology, Inc.
$15
Adaptive Biotechnologies Corporation
$13
Rigel Pharmaceuticals, Inc.
$9
Top 3 companies account for 29.8% of all-time payments
Associated products mentioned in payments ›
Alecensa · BRUKINSA · Blincyto · CYRAMZA · ENHERTU · ENJAYMO · EPKINLY · Enhertu · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INTERA · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUMAKRAS · Lenvima · MONJUVI · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OPDIVO · Orserdu · PROMACTA · REBLOZYL · ROZLYTREK · Revlimid · Rezlidhia · SARCLISA · SUTENT · Soliris · TAGRISSO · TUKYSA · VERZENIO · VONJO · VYXEOS · Vectibix · XARELTO · Xospata · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
74
Per 100K population
19.0
County median income
$81,194
Nearest hospital
MERCY HEALTH - FAIRFIELD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mettu is a mixed practice specialist, with above-average Medicare volume (top 17% in OH), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mettu experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Mettu performed 7,650 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mettu receive payments from pharmaceutical companies?
Yes. Dr. Mettu received a total of $2,846 from 37 companies across 115 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mettu's costs compare to other hematology & oncology specialists in Fairfield?
Dr. Mettu's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mettu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fairfield
Browse hematology & oncology specialists in Fairfield ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology